Aclasta is used to treat osteoporosis. It can prevent additional fractures in vulnerable men and women, as well as Paget’s disease. We offer IV Aclasta infusions for patients, and this is arranged when requested by your doctor.
Osteoporosis is a disease which causes bones to become less dense, gradually making them weaker, more brittle and likely to break. This is common in women after menopause, when a woman’s ovaries stop producing the female hormone, oestrogen, which keeps bones healthy. It also occurs in men and women with increasing age.
Aclasta is also used to treat Paget’s disease. Paget’s disease is a chronic disorder which may affect various bones. In Paget’s disease, the bone material breaks down more quickly than usual, and new bone grows more quickly than usual and in a disordered way. The new bone that is formed may be thicker but weaker than normal, which can cause pain and may lead to fractures.
If you think you may be suitable for an Aclasta infusion, make an appointment and discuss with your doctor.
If your doctor feels Aclasta is appropriate for you and you wish to proceed with this treatment, a nurse will contact you to make the necessary arrangements.
Ferinject is an intravenous iron preparation, a medicine that is used in the treatment of iron deficiency conditions. Iron is an essential element required for the oxygen-carrying capacity of haemoglobin in red blood cells and of myoglobin in muscle tissue and plays an important role in many other vital processes in the human body.
This treatment is prescribed when oral iron preparations are ineffective or cannot be used. The aim of the therapy is to replenish body iron stores and to remedy anaemia, a reduced level of haemoglobin due to iron deficiency.
If your doctor feels Ferinject is the appropriate for you and you wish to proceed with this treatment, a nurse will contact you to make the necessary arrangements.